1 Market Overview

1.1 Product Overview and Scope of β Adrenoceptor Agonists

1.2 Classification of β Adrenoceptor Agonists by Type

1.2.1 Overview: Global β Adrenoceptor Agonists Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global β Adrenoceptor Agonists Revenue Market Share by Type in 2021

1.2.3 Isoprenaline

1.2.4 Dobutamine

1.2.5 Salbutamol

1.2.6 Terbutaline

1.2.7 Salmeterol

1.2.8 Formoterol

1.2.9 Pirbuterol

1.3 Global β Adrenoceptor Agonists Market by Application

1.3.1 Overview: Global β Adrenoceptor Agonists Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Chronic Heart Failure

1.3.3 Myocardial Infarction

1.3.4 Postoperative Hypotension

1.3.5 Bronchial Asthma

1.3.6 Asthmatic Bronchitis

1.3.7 Emphysema

1.3.8 Others

1.4 Global β Adrenoceptor Agonists Market Size & Forecast

1.5 Global β Adrenoceptor Agonists Market Size and Forecast by Region

1.5.1 Global β Adrenoceptor Agonists Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global β Adrenoceptor Agonists Market Size by Region, (2017-2022)

1.5.3 North America β Adrenoceptor Agonists Market Size and Prospect (2017-2028)

1.5.4 Europe β Adrenoceptor Agonists Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific β Adrenoceptor Agonists Market Size and Prospect (2017-2028)

1.5.6 South America β Adrenoceptor Agonists Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa β Adrenoceptor Agonists Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 β Adrenoceptor Agonists Market Drivers

1.6.2 β Adrenoceptor Agonists Market Restraints

1.6.3 β Adrenoceptor Agonists Trends Analysis

2 Company Profiles

2.1 Ivax Pharmaceuticals 

2.1.1 Ivax Pharmaceuticals  Details

2.1.2 Ivax Pharmaceuticals  Major Business

2.1.3 Ivax Pharmaceuticals  β Adrenoceptor Agonists Product and Solutions

2.1.4 Ivax Pharmaceuticals  β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Ivax Pharmaceuticals  Recent Developments and Future Plans

2.2 Physicians Total Care

2.2.1 Physicians Total Care Details

2.2.2 Physicians Total Care Major Business

2.2.3 Physicians Total Care β Adrenoceptor Agonists Product and Solutions

2.2.4 Physicians Total Care β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Physicians Total Care Recent Developments and Future Plans

2.3 Baxter Healthcare 

2.3.1 Baxter Healthcare  Details

2.3.2 Baxter Healthcare  Major Business

2.3.3 Baxter Healthcare  β Adrenoceptor Agonists Product and Solutions

2.3.4 Baxter Healthcare  β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Baxter Healthcare  Recent Developments and Future Plans

2.4 Sanofi

2.4.1 Sanofi Details

2.4.2 Sanofi Major Business

2.4.3 Sanofi β Adrenoceptor Agonists Product and Solutions

2.4.4 Sanofi β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Sanofi Recent Developments and Future Plans

2.5 Pfizer

2.5.1 Pfizer Details

2.5.2 Pfizer Major Business

2.5.3 Pfizer β Adrenoceptor Agonists Product and Solutions

2.5.4 Pfizer β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Pfizer Recent Developments and Future Plans

2.6 Bedford Laboratories

2.6.1 Bedford Laboratories Details

2.6.2 Bedford Laboratories Major Business

2.6.3 Bedford Laboratories β Adrenoceptor Agonists Product and Solutions

2.6.4 Bedford Laboratories β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Bedford Laboratories Recent Developments and Future Plans

2.7 Novartis

2.7.1 Novartis Details

2.7.2 Novartis Major Business

2.7.3 Novartis β Adrenoceptor Agonists Product and Solutions

2.7.4 Novartis β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Novartis Recent Developments and Future Plans

2.8 Sterimax

2.8.1 Sterimax Details

2.8.2 Sterimax Major Business

2.8.3 Sterimax β Adrenoceptor Agonists Product and Solutions

2.8.4 Sterimax β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Sterimax Recent Developments and Future Plans

2.9 Teligent

2.9.1 Teligent Details

2.9.2 Teligent Major Business

2.9.3 Teligent β Adrenoceptor Agonists Product and Solutions

2.9.4 Teligent β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Teligent Recent Developments and Future Plans

2.10 AstraZeneca

2.10.1 AstraZeneca Details

2.10.2 AstraZeneca Major Business

2.10.3 AstraZeneca β Adrenoceptor Agonists Product and Solutions

2.10.4 AstraZeneca β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 AstraZeneca Recent Developments and Future Plans

2.11 Hikma Pharmaceuticals

2.11.1 Hikma Pharmaceuticals Details

2.11.2 Hikma Pharmaceuticals Major Business

2.11.3 Hikma Pharmaceuticals β Adrenoceptor Agonists Product and Solutions

2.11.4 Hikma Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Hikma Pharmaceuticals Recent Developments and Future Plans

2.12 Av Kare

2.12.1 Av Kare Details

2.12.2 Av Kare Major Business

2.12.3 Av Kare β Adrenoceptor Agonists Product and Solutions

2.12.4 Av Kare β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Av Kare Recent Developments and Future Plans

2.13 Impax Laboratories

2.13.1 Impax Laboratories Details

2.13.2 Impax Laboratories Major Business

2.13.3 Impax Laboratories β Adrenoceptor Agonists Product and Solutions

2.13.4 Impax Laboratories β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Impax Laboratories Recent Developments and Future Plans

2.14 PD-Rx Pharmaceuticals

2.14.1 PD-Rx Pharmaceuticals Details

2.14.2 PD-Rx Pharmaceuticals Major Business

2.14.3 PD-Rx Pharmaceuticals β Adrenoceptor Agonists Product and Solutions

2.14.4 PD-Rx Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 PD-Rx Pharmaceuticals Recent Developments and Future Plans

2.15 Athenex Pharmaceutical Division

2.15.1 Athenex Pharmaceutical Division Details

2.15.2 Athenex Pharmaceutical Division Major Business

2.15.3 Athenex Pharmaceutical Division β Adrenoceptor Agonists Product and Solutions

2.15.4 Athenex Pharmaceutical Division β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Athenex Pharmaceutical Division Recent Developments and Future Plans

2.16 Teva

2.16.1 Teva Details

2.16.2 Teva Major Business

2.16.3 Teva β Adrenoceptor Agonists Product and Solutions

2.16.4 Teva β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16.5 Teva Recent Developments and Future Plans

2.17 Marlex Pharmaceuticals

2.17.1 Marlex Pharmaceuticals Details

2.17.2 Marlex Pharmaceuticals Major Business

2.17.3 Marlex Pharmaceuticals β Adrenoceptor Agonists Product and Solutions

2.17.4 Marlex Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17.5 Marlex Pharmaceuticals Recent Developments and Future Plans

2.18 Lannett Company

2.18.1 Lannett Company Details

2.18.2 Lannett Company Major Business

2.18.3 Lannett Company β Adrenoceptor Agonists Product and Solutions

2.18.4 Lannett Company β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18.5 Lannett Company Recent Developments and Future Plans

2.19 West-Ward Pharmaceuticals

2.19.1 West-Ward Pharmaceuticals Details

2.19.2 West-Ward Pharmaceuticals Major Business

2.19.3 West-Ward Pharmaceuticals β Adrenoceptor Agonists Product and Solutions

2.19.4 West-Ward Pharmaceuticals β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.19.5 West-Ward Pharmaceuticals Recent Developments and Future Plans

2.20 United Biomedical

2.20.1 United Biomedical Details

2.20.2 United Biomedical Major Business

2.20.3 United Biomedical β Adrenoceptor Agonists Product and Solutions

2.20.4 United Biomedical β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.20.5 United Biomedical Recent Developments and Future Plans

2.21 Merck

2.21.1 Merck Details

2.21.2 Merck Major Business

2.21.3 Merck β Adrenoceptor Agonists Product and Solutions

2.21.4 Merck β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.21.5 Merck Recent Developments and Future Plans

2.22 Mylan

2.22.1 Mylan Details

2.22.2 Mylan Major Business

2.22.3 Mylan β Adrenoceptor Agonists Product and Solutions

2.22.4 Mylan β Adrenoceptor Agonists Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.22.5 Mylan Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global β Adrenoceptor Agonists Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 β Adrenoceptor Agonists Players Market Share in 2021

3.2.2 Top 10 β Adrenoceptor Agonists Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 β Adrenoceptor Agonists Players Head Office, Products and Services Provided

3.4 β Adrenoceptor Agonists Mergers & Acquisitions

3.5 β Adrenoceptor Agonists New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global β Adrenoceptor Agonists Revenue and Market Share by Type (2017-2022)

4.2 Global β Adrenoceptor Agonists Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global β Adrenoceptor Agonists Revenue Market Share by Application (2017-2022)

5.2 Global β Adrenoceptor Agonists Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America β Adrenoceptor Agonists Revenue by Type (2017-2028)

6.2 North America β Adrenoceptor Agonists Revenue by Application (2017-2028)

6.3 North America β Adrenoceptor Agonists Market Size by Country

6.3.1 North America β Adrenoceptor Agonists Revenue by Country (2017-2028)

6.3.2 United States β Adrenoceptor Agonists Market Size and Forecast (2017-2028)

6.3.3 Canada β Adrenoceptor Agonists Market Size and Forecast (2017-2028)

6.3.4 Mexico β Adrenoceptor Agonists Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe β Adrenoceptor Agonists Revenue by Type (2017-2028)

7.2 Europe β Adrenoceptor Agonists Revenue by Application (2017-2028)

7.3 Europe β Adrenoceptor Agonists Market Size by Country

7.3.1 Europe β Adrenoceptor Agonists Revenue by Country (2017-2028)

7.3.2 Germany β Adrenoceptor Agonists Market Size and Forecast (2017-2028)

7.3.3 France β Adrenoceptor Agonists Market Size and Forecast (2017-2028)

7.3.4 United Kingdom β Adrenoceptor Agonists Market Size and Forecast (2017-2028)

7.3.5 Russia β Adrenoceptor Agonists Market Size and Forecast (2017-2028)

7.3.6 Italy β Adrenoceptor Agonists Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific β Adrenoceptor Agonists Revenue by Type (2017-2028)

8.2 Asia-Pacific β Adrenoceptor Agonists Revenue by Application (2017-2028)

8.3 Asia-Pacific β Adrenoceptor Agonists Market Size by Region

8.3.1 Asia-Pacific β Adrenoceptor Agonists Revenue by Region (2017-2028)

8.3.2 China β Adrenoceptor Agonists Market Size and Forecast (2017-2028)

8.3.3 Japan β Adrenoceptor Agonists Market Size and Forecast (2017-2028)

8.3.4 South Korea β Adrenoceptor Agonists Market Size and Forecast (2017-2028)

8.3.5 India β Adrenoceptor Agonists Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia β Adrenoceptor Agonists Market Size and Forecast (2017-2028)

8.3.7 Australia β Adrenoceptor Agonists Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America β Adrenoceptor Agonists Revenue by Type (2017-2028)

9.2 South America β Adrenoceptor Agonists Revenue by Application (2017-2028)

9.3 South America β Adrenoceptor Agonists Market Size by Country

9.3.1 South America β Adrenoceptor Agonists Revenue by Country (2017-2028)

9.3.2 Brazil β Adrenoceptor Agonists Market Size and Forecast (2017-2028)

9.3.3 Argentina β Adrenoceptor Agonists Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa β Adrenoceptor Agonists Revenue by Type (2017-2028)

10.2 Middle East & Africa β Adrenoceptor Agonists Revenue by Application (2017-2028)

10.3 Middle East & Africa β Adrenoceptor Agonists Market Size by Country

10.3.1 Middle East & Africa β Adrenoceptor Agonists Revenue by Country (2017-2028)

10.3.2 Turkey β Adrenoceptor Agonists Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia β Adrenoceptor Agonists Market Size and Forecast (2017-2028)

10.3.4 UAE β Adrenoceptor Agonists Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global β Adrenoceptor Agonists Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global β Adrenoceptor Agonists Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market β Adrenoceptor Agonists Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global β Adrenoceptor Agonists Revenue (USD Million) by Region (2017-2022)

Table 5. Global β Adrenoceptor Agonists Revenue Market Share by Region (2023-2028)

Table 6. Ivax Pharmaceuticals  Corporate Information, Head Office, and Major Competitors

Table 7. Ivax Pharmaceuticals  Major Business

Table 8. Ivax Pharmaceuticals  β Adrenoceptor Agonists Product and Solutions

Table 9. Ivax Pharmaceuticals  β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Physicians Total Care Corporate Information, Head Office, and Major Competitors

Table 11. Physicians Total Care Major Business

Table 12. Physicians Total Care β Adrenoceptor Agonists Product and Solutions

Table 13. Physicians Total Care β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Baxter Healthcare  Corporate Information, Head Office, and Major Competitors

Table 15. Baxter Healthcare  Major Business

Table 16. Baxter Healthcare  β Adrenoceptor Agonists Product and Solutions

Table 17. Baxter Healthcare  β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Sanofi Corporate Information, Head Office, and Major Competitors

Table 19. Sanofi Major Business

Table 20. Sanofi β Adrenoceptor Agonists Product and Solutions

Table 21. Sanofi β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Pfizer Corporate Information, Head Office, and Major Competitors

Table 23. Pfizer Major Business

Table 24. Pfizer β Adrenoceptor Agonists Product and Solutions

Table 25. Pfizer β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Bedford Laboratories Corporate Information, Head Office, and Major Competitors

Table 27. Bedford Laboratories Major Business

Table 28. Bedford Laboratories β Adrenoceptor Agonists Product and Solutions

Table 29. Bedford Laboratories β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Novartis Corporate Information, Head Office, and Major Competitors

Table 31. Novartis Major Business

Table 32. Novartis β Adrenoceptor Agonists Product and Solutions

Table 33. Novartis β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Sterimax Corporate Information, Head Office, and Major Competitors

Table 35. Sterimax Major Business

Table 36. Sterimax β Adrenoceptor Agonists Product and Solutions

Table 37. Sterimax β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Teligent Corporate Information, Head Office, and Major Competitors

Table 39. Teligent Major Business

Table 40. Teligent β Adrenoceptor Agonists Product and Solutions

Table 41. Teligent β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. AstraZeneca Corporate Information, Head Office, and Major Competitors

Table 43. AstraZeneca Major Business

Table 44. AstraZeneca β Adrenoceptor Agonists Product and Solutions

Table 45. AstraZeneca β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Hikma Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 47. Hikma Pharmaceuticals Major Business

Table 48. Hikma Pharmaceuticals β Adrenoceptor Agonists Product and Solutions

Table 49. Hikma Pharmaceuticals β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Av Kare Corporate Information, Head Office, and Major Competitors

Table 51. Av Kare Major Business

Table 52. Av Kare β Adrenoceptor Agonists Product and Solutions

Table 53. Av Kare β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Impax Laboratories Corporate Information, Head Office, and Major Competitors

Table 55. Impax Laboratories Major Business

Table 56. Impax Laboratories β Adrenoceptor Agonists Product and Solutions

Table 57. Impax Laboratories β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. PD-Rx Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 59. PD-Rx Pharmaceuticals Major Business

Table 60. PD-Rx Pharmaceuticals β Adrenoceptor Agonists Product and Solutions

Table 61. PD-Rx Pharmaceuticals β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Athenex Pharmaceutical Division Corporate Information, Head Office, and Major Competitors

Table 63. Athenex Pharmaceutical Division Major Business

Table 64. Athenex Pharmaceutical Division β Adrenoceptor Agonists Product and Solutions

Table 65. Athenex Pharmaceutical Division β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Teva Corporate Information, Head Office, and Major Competitors

Table 67. Teva Major Business

Table 68. Teva β Adrenoceptor Agonists Product and Solutions

Table 69. Teva β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 70. Marlex Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 71. Marlex Pharmaceuticals Major Business

Table 72. Marlex Pharmaceuticals β Adrenoceptor Agonists Product and Solutions

Table 73. Marlex Pharmaceuticals β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 74. Lannett Company Corporate Information, Head Office, and Major Competitors

Table 75. Lannett Company Major Business

Table 76. Lannett Company β Adrenoceptor Agonists Product and Solutions

Table 77. Lannett Company β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 78. West-Ward Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 79. West-Ward Pharmaceuticals Major Business

Table 80. West-Ward Pharmaceuticals β Adrenoceptor Agonists Product and Solutions

Table 81. West-Ward Pharmaceuticals β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 82. United Biomedical Corporate Information, Head Office, and Major Competitors

Table 83. United Biomedical Major Business

Table 84. United Biomedical β Adrenoceptor Agonists Product and Solutions

Table 85. United Biomedical β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 86. Merck Corporate Information, Head Office, and Major Competitors

Table 87. Merck Major Business

Table 88. Merck β Adrenoceptor Agonists Product and Solutions

Table 89. Merck β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 90. Mylan Corporate Information, Head Office, and Major Competitors

Table 91. Mylan Major Business

Table 92. Mylan β Adrenoceptor Agonists Product and Solutions

Table 93. Mylan β Adrenoceptor Agonists Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 94. Global β Adrenoceptor Agonists Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 95. Global β Adrenoceptor Agonists Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 96. Breakdown of β Adrenoceptor Agonists by Company Type (Tier 1, Tier 2 and Tier 3)

Table 97. β Adrenoceptor Agonists Players Head Office, Products and Services Provided

Table 98. β Adrenoceptor Agonists Mergers & Acquisitions in the Past Five Years

Table 99. β Adrenoceptor Agonists New Entrants and Expansion Plans

Table 100. Global β Adrenoceptor Agonists Revenue (USD Million) by Type (2017-2022)

Table 101. Global β Adrenoceptor Agonists Revenue Share by Type (2017-2022)

Table 102. Global β Adrenoceptor Agonists Revenue Forecast by Type (2023-2028)

Table 103. Global β Adrenoceptor Agonists Revenue by Application (2017-2022)

Table 104. Global β Adrenoceptor Agonists Revenue Forecast by Application (2023-2028)

Table 105. North America β Adrenoceptor Agonists Revenue by Type (2017-2022) & (USD Million)

Table 106. North America β Adrenoceptor Agonists Revenue by Type (2023-2028) & (USD Million)

Table 107. North America β Adrenoceptor Agonists Revenue by Application (2017-2022) & (USD Million)

Table 108. North America β Adrenoceptor Agonists Revenue by Application (2023-2028) & (USD Million)

Table 109. North America β Adrenoceptor Agonists Revenue by Country (2017-2022) & (USD Million)

Table 110. North America β Adrenoceptor Agonists Revenue by Country (2023-2028) & (USD Million)

Table 111. Europe β Adrenoceptor Agonists Revenue by Type (2017-2022) & (USD Million)

Table 112. Europe β Adrenoceptor Agonists Revenue by Type (2023-2028) & (USD Million)

Table 113. Europe β Adrenoceptor Agonists Revenue by Application (2017-2022) & (USD Million)

Table 114. Europe β Adrenoceptor Agonists Revenue by Application (2023-2028) & (USD Million)

Table 115. Europe β Adrenoceptor Agonists Revenue by Country (2017-2022) & (USD Million)

Table 116. Europe β Adrenoceptor Agonists Revenue by Country (2023-2028) & (USD Million)

Table 117. Asia-Pacific β Adrenoceptor Agonists Revenue by Type (2017-2022) & (USD Million)

Table 118. Asia-Pacific β Adrenoceptor Agonists Revenue by Type (2023-2028) & (USD Million)

Table 119. Asia-Pacific β Adrenoceptor Agonists Revenue by Application (2017-2022) & (USD Million)

Table 120. Asia-Pacific β Adrenoceptor Agonists Revenue by Application (2023-2028) & (USD Million)

Table 121. Asia-Pacific β Adrenoceptor Agonists Revenue by Region (2017-2022) & (USD Million)

Table 122. Asia-Pacific β Adrenoceptor Agonists Revenue by Region (2023-2028) & (USD Million)

Table 123. South America β Adrenoceptor Agonists Revenue by Type (2017-2022) & (USD Million)

Table 124. South America β Adrenoceptor Agonists Revenue by Type (2023-2028) & (USD Million)

Table 125. South America β Adrenoceptor Agonists Revenue by Application (2017-2022) & (USD Million)

Table 126. South America β Adrenoceptor Agonists Revenue by Application (2023-2028) & (USD Million)

Table 127. South America β Adrenoceptor Agonists Revenue by Country (2017-2022) & (USD Million)

Table 128. South America β Adrenoceptor Agonists Revenue by Country (2023-2028) & (USD Million)

Table 129. Middle East & Africa β Adrenoceptor Agonists Revenue by Type (2017-2022) & (USD Million)

Table 130. Middle East & Africa β Adrenoceptor Agonists Revenue by Type (2023-2028) & (USD Million)

Table 131. Middle East & Africa β Adrenoceptor Agonists Revenue by Application (2017-2022) & (USD Million)

Table 132. Middle East & Africa β Adrenoceptor Agonists Revenue by Application (2023-2028) & (USD Million)

Table 133. Middle East & Africa β Adrenoceptor Agonists Revenue by Country (2017-2022) & (USD Million)

Table 134. Middle East & Africa β Adrenoceptor Agonists Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. β Adrenoceptor Agonists Picture

Figure 2. Global β Adrenoceptor Agonists Revenue Market Share by Type in 2021

Figure 3. Isoprenaline

Figure 4. Dobutamine

Figure 5. Salbutamol

Figure 6. Terbutaline

Figure 7. Salmeterol

Figure 8. Formoterol

Figure 9. Pirbuterol

Figure 10. β Adrenoceptor Agonists Revenue Market Share by Application in 2021

Figure 11. Chronic Heart Failure Picture

Figure 12. Myocardial Infarction Picture

Figure 13. Postoperative Hypotension Picture

Figure 14. Bronchial Asthma Picture

Figure 15. Asthmatic Bronchitis Picture

Figure 16. Emphysema Picture

Figure 17. Others Picture

Figure 18. Global β Adrenoceptor Agonists Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 19. Global β Adrenoceptor Agonists Revenue and Forecast (2017-2028) & (USD Million)

Figure 20. Global β Adrenoceptor Agonists Revenue Market Share by Region (2017-2028)

Figure 21. Global β Adrenoceptor Agonists Revenue Market Share by Region in 2021

Figure 22. North America β Adrenoceptor Agonists Revenue (USD Million) and Growth Rate (2017-2028)

Figure 23. Europe β Adrenoceptor Agonists Revenue (USD Million) and Growth Rate (2017-2028)

Figure 24. Asia-Pacific β Adrenoceptor Agonists Revenue (USD Million) and Growth Rate (2017-2028)

Figure 25. South America β Adrenoceptor Agonists Revenue (USD Million) and Growth Rate (2017-2028)

Figure 26. Middle East and Africa β Adrenoceptor Agonists Revenue (USD Million) and Growth Rate (2017-2028)

Figure 27. β Adrenoceptor Agonists Market Drivers

Figure 28. β Adrenoceptor Agonists Market Restraints

Figure 29. β Adrenoceptor Agonists Market Trends

Figure 30. Ivax Pharmaceuticals  Recent Developments and Future Plans

Figure 31. Physicians Total Care Recent Developments and Future Plans

Figure 32. Baxter Healthcare  Recent Developments and Future Plans

Figure 33. Sanofi Recent Developments and Future Plans

Figure 34. Pfizer Recent Developments and Future Plans

Figure 35. Bedford Laboratories Recent Developments and Future Plans

Figure 36. Novartis Recent Developments and Future Plans

Figure 37. Sterimax Recent Developments and Future Plans

Figure 38. Teligent Recent Developments and Future Plans

Figure 39. AstraZeneca Recent Developments and Future Plans

Figure 40. Hikma Pharmaceuticals Recent Developments and Future Plans

Figure 41. Av Kare Recent Developments and Future Plans

Figure 42. Impax Laboratories Recent Developments and Future Plans

Figure 43. PD-Rx Pharmaceuticals Recent Developments and Future Plans

Figure 44. Athenex Pharmaceutical Division Recent Developments and Future Plans

Figure 45. Teva Recent Developments and Future Plans

Figure 46. Marlex Pharmaceuticals Recent Developments and Future Plans

Figure 47. Lannett Company Recent Developments and Future Plans

Figure 48. West-Ward Pharmaceuticals Recent Developments and Future Plans

Figure 49. United Biomedical Recent Developments and Future Plans

Figure 50. Merck Recent Developments and Future Plans

Figure 51. Mylan Recent Developments and Future Plans

Figure 52. Global β Adrenoceptor Agonists Revenue Share by Players in 2021

Figure 53. β Adrenoceptor Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 54. Global Top 3 Players β Adrenoceptor Agonists Revenue Market Share in 2021

Figure 55. Global Top 10 Players β Adrenoceptor Agonists Revenue Market Share in 2021

Figure 56. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 57. Global β Adrenoceptor Agonists Revenue Share by Type in 2021

Figure 58. Global β Adrenoceptor Agonists Market Share Forecast by Type (2023-2028)

Figure 59. Global β Adrenoceptor Agonists Revenue Share by Application in 2021

Figure 60. Global β Adrenoceptor Agonists Market Share Forecast by Application (2023-2028)

Figure 61. North America β Adrenoceptor Agonists Sales Market Share by Type (2017-2028)

Figure 62. North America β Adrenoceptor Agonists Sales Market Share by Application (2017-2028)

Figure 63. North America β Adrenoceptor Agonists Revenue Market Share by Country (2017-2028)

Figure 64. United States β Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Canada β Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Mexico β Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Europe β Adrenoceptor Agonists Sales Market Share by Type (2017-2028)

Figure 68. Europe β Adrenoceptor Agonists Sales Market Share by Application (2017-2028)

Figure 69. Europe β Adrenoceptor Agonists Revenue Market Share by Country (2017-2028)

Figure 70. Germany β Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. France β Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. United Kingdom β Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Russia β Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Italy β Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Asia-Pacific β Adrenoceptor Agonists Sales Market Share by Type (2017-2028)

Figure 76. Asia-Pacific β Adrenoceptor Agonists Sales Market Share by Application (2017-2028)

Figure 77. Asia-Pacific β Adrenoceptor Agonists Revenue Market Share by Region (2017-2028)

Figure 78. China β Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Japan β Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. South Korea β Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. India β Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. Southeast Asia β Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 83. Australia β Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 84. South America β Adrenoceptor Agonists Sales Market Share by Type (2017-2028)

Figure 85. South America β Adrenoceptor Agonists Sales Market Share by Application (2017-2028)

Figure 86. South America β Adrenoceptor Agonists Revenue Market Share by Country (2017-2028)

Figure 87. Brazil β Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 88. Argentina β Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 89. Middle East and Africa β Adrenoceptor Agonists Sales Market Share by Type (2017-2028)

Figure 90. Middle East and Africa β Adrenoceptor Agonists Sales Market Share by Application (2017-2028)

Figure 91. Middle East and Africa β Adrenoceptor Agonists Revenue Market Share by Country (2017-2028)

Figure 92. Turkey β Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 93. Saudi Arabia β Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 94. UAE β Adrenoceptor Agonists Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 95. Methodology

Figure 96. Research Process and Data Source